SUBSCRIBERS
Nuvation Bio raises US$275m in funds with EDBI, Pavilion taking part
Ng Ren Jye
Published Tue, Oct 29, 2019 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SINGAPORE Economic Development Board's investment arm, EDBI, and Temasek Holdings subsidiary Pavilion Capital took part in a US$275 million oversubscribed Series A round for US-based biotech startup Nuvation Bio.
The round was led, structured and syndicated by Boston-based Omega Funds, and included participation from Aisling Capital, Altitude Life Science Ventures and Baupost Group, among other investors, the startup said on Tuesday.
Copyright SPH Media. All rights reserved.